Melanoma Monitoring Solution
Melanoma
CommercialActive
Key Facts
About Oncobit
Oncobit is a private, commercial-stage diagnostics company based in Lausanne, Switzerland, specializing in liquid biopsy solutions for cancer monitoring. Its core offering is a CE-IVDR-marked digital PCR-based platform and software for detecting and tracking ctDNA, initially focused on melanoma. The company is actively expanding its market presence through strategic partnerships with diagnostic firms like ID Solutions and TrilliumBiO, and is engaged in a major clinical utility study to integrate ctDNA monitoring into routine melanoma follow-up.
View full company profileTherapeutic Areas
Other Melanoma Drugs
| Drug | Company | Phase |
|---|---|---|
| ABD-3001 | Advanced Biodesign | Phase 1 |
| SUPLEXA | Alloplex Biotherapeutics | Phase 1 |
| Cannabics® MLN-33 | CNBX Pharmaceuticals | Discovery |
| AV-MEL-1 | AIVITA Biomedical | Phase 1B |
| Melanoma Immunotherapy | Vaccizone | Pre-clinical |
| Undisclosed RNA Immunotherapy | Epitopea | Pre-clinical |
| Undisclosed Enhanced Antibody Program | Score Pharma | Pre-clinical |
| ASO for Melanoma | Carnation Therapeutics | Pre-clinical |
| Personalized DNA Cancer Vaccine | Neomatrix | Pre-clinical |